Segment Reporting (Tables)

3 Months Ended

Mar. 31, 2015

Segment Reporting Information By Segment

A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying unaudited condensed consolidated statements of operations is as follows:



	Three Months Ended March 31,
(in millions)	2015			2014

Net sales
Interventional Cardiology	$	541		$	501
Peripheral Interventions	232			204
Cardiovascular	773			705

Cardiac Rhythm Management	483			464
Electrophysiology	61			58
Rhythm Management	544			522

Endoscopy	328			316
Urology and Women's Health	130			126
Neuromodulation	116			109
MedSurg	574			551
Net sales allocated to reportable segments	1,891			1,778
Sales generated from divested businesses	—			2
Impact of foreign currency fluctuations	(123		)	(6		)
	$	1,768		$	1,774

Income (loss) before income taxes
Cardiovascular	$	236		$	171
Rhythm Management	78			66
MedSurg	166			168
Operating income allocated to reportable segments	480			405
Corporate expenses and currency exchange	(82		)	(50		)
Goodwill and other intangible asset impairment charges; and acquisition-, divestiture-, restructuring-, litigation related charges or credits, and pension termination charges	(261		)	(49		)
Amortization expense	(113		)	(109		)
Operating income (loss)	24			197
Other expense, net	(75		)	(51		)
Income (loss) before income taxes	$	(51	)	$	146

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details